IRIS
FERRARI, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.728
NA - Nord America 8.648
EU - Europa 4.842
SA - Sud America 1.192
AF - Africa 466
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 7
Totale 23.910
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.416
SG - Singapore 3.066
CN - Cina 2.230
VN - Vietnam 1.248
IT - Italia 1.007
IE - Irlanda 935
BR - Brasile 922
SE - Svezia 707
HK - Hong Kong 644
BD - Bangladesh 513
DE - Germania 492
FI - Finlandia 399
FR - Francia 394
TR - Turchia 385
ZA - Sudafrica 328
NL - Olanda 278
CA - Canada 141
IN - India 136
GB - Regno Unito 126
UA - Ucraina 106
RU - Federazione Russa 97
AR - Argentina 96
JP - Giappone 76
IQ - Iraq 64
KR - Corea 55
MX - Messico 51
CI - Costa d'Avorio 43
EC - Ecuador 41
PK - Pakistan 40
PL - Polonia 40
AT - Austria 38
BE - Belgio 37
VE - Venezuela 37
ID - Indonesia 36
PH - Filippine 35
CO - Colombia 34
ES - Italia 33
TH - Thailandia 31
DK - Danimarca 29
UZ - Uzbekistan 27
MA - Marocco 23
AU - Australia 22
LT - Lituania 22
KE - Kenya 21
RO - Romania 20
TW - Taiwan 20
PY - Paraguay 17
CZ - Repubblica Ceca 15
EG - Egitto 14
SA - Arabia Saudita 14
UY - Uruguay 13
CL - Cile 11
OM - Oman 11
BO - Bolivia 10
JO - Giordania 10
AZ - Azerbaigian 9
IL - Israele 9
MY - Malesia 9
PE - Perù 9
BG - Bulgaria 8
CH - Svizzera 8
KZ - Kazakistan 8
TN - Tunisia 8
GR - Grecia 7
IR - Iran 7
LV - Lettonia 7
PA - Panama 7
AE - Emirati Arabi Uniti 6
PT - Portogallo 6
AL - Albania 5
BY - Bielorussia 5
EU - Europa 5
HN - Honduras 5
NP - Nepal 5
DO - Repubblica Dominicana 4
GT - Guatemala 4
KG - Kirghizistan 4
LB - Libano 4
MD - Moldavia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
RS - Serbia 4
SY - Repubblica araba siriana 4
BB - Barbados 3
CR - Costa Rica 3
DZ - Algeria 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
LU - Lussemburgo 3
NG - Nigeria 3
SN - Senegal 3
SV - El Salvador 3
TG - Togo 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
GA - Gabon 2
HU - Ungheria 2
Totale 23.872
Salva come PNG Salva come JPEG
Città #
Singapore 1.451
Ashburn 1.061
San Jose 991
Dublin 934
Chandler 729
Santa Clara 635
Hong Kong 617
Dallas 522
Beijing 454
Dearborn 409
Ho Chi Minh City 376
Johannesburg 307
Izmir 300
Boardman 298
Hanoi 294
Nanjing 250
New York 221
Parma 201
Princeton 200
Munich 196
Lauterbourg 195
Los Angeles 187
Shanghai 158
Ann Arbor 155
Wilmington 152
Helsinki 134
Jacksonville 109
Columbus 107
São Paulo 94
Milan 86
Buffalo 77
Shenyang 77
Hebei 74
Rome 71
Hefei 65
Nanchang 64
Council Bluffs 63
Moscow 62
Chicago 60
Tianjin 59
Tokyo 58
Da Nang 57
Toronto 57
Haiphong 55
Kunming 54
Seattle 54
Jinan 51
The Dalles 48
Guangzhou 47
Düsseldorf 44
Abidjan 43
Grafing 42
Jiaxing 42
Rio de Janeiro 42
Changsha 41
Bremen 40
Frankfurt am Main 39
Houston 39
Kocaeli 39
Montreal 38
San Mateo 37
London 35
Stockholm 35
Bologna 34
Norwalk 34
Brussels 32
Des Moines 32
Nuremberg 31
Zhengzhou 30
Warsaw 29
Turku 28
Hải Dương 27
Seoul 26
Vienna 26
Brooklyn 25
Marseille 25
Tashkent 25
Baghdad 24
Phoenix 23
Taastrup 23
Belo Horizonte 22
Hangzhou 22
Curitiba 21
Mestre 21
Orem 21
Atlanta 20
Charlotte 19
Denver 19
Jakarta 19
Brasília 18
Naples 18
Pune 18
San Francisco 18
Bengaluru 17
Boston 17
Mexico City 17
Reggio Emilia 17
Washington 17
Can Tho 16
Ardea 15
Totale 14.378
Salva come PNG Salva come JPEG
Nome #
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 318
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 303
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 289
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 283
Anti-Viral Intrahepatic T-Cell Responses can be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B 211
A simplified sars-cov-2 pseudovirus neutralization assay 211
TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues 206
Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus 203
The anti-COVID-19 vaccine unveils latent systemic sclerosis 201
Therapeutic potential of co-signaling receptor modulation in hepatitis B 191
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 185
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 185
Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study 185
Metabolic regulation of the HBV-specific T cell function 176
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients 175
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 174
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19 174
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma 166
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 162
ALTERAZIONI DELLA FUNZIONALITA’ TIROIDEA IN PAZIENTI AFFETTI DA EPATITE CRONICA ATTIVA DA VIRUS C IN TERAPIA CON INTERFERONE E RIBAVIRINA E CORRELAZIONE CON LA RISPOSTA ALLA TERAPIA ANTIVIRALE 161
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 158
Alterazioni della funzionalità tiroidea in pazienti affetti da epatite cronica attiva da virus C in terapia con interferone e ribavirina e correlazione con la risposta alla terapia antivirale. 157
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection 156
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 155
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 154
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 151
Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm 151
Adaptive immunity in HBV infection 150
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 150
HBV immune-therapy: From molecular mechanisms to clinical applications 149
Le linee di ricerca strategiche di un'azienda ospedaliero-universitaria: proposta di un metodo qualiquantitativo 148
Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. 146
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 146
Clonal analysis of intrahepatic T lymphocytes in chronic active hepatitis. Isolation of a T-cell line specific for hepatitis B core antigen from a patient with serological evidence of exposure to HBV. J. Hepatol. 144
[An outbreak type A hepatitis in a family group living in a village near Parma. Epidemiologic evaluation and prophylaxis (author's transl)] 144
Ex vivo characterization of tumor-derived melanoma antigenencoding gene-specific CD8 1 cells in patientswith hepatocellular carcinoma 143
T cell regulation in HBV-related chronic liver disease 143
Practice of proctology among general surgery residents and young specialists in Italy: a snapshot survey 142
Tiroiditi distruttive in pazienti affetti da epatite cronica attiva da virus C in terapia con interferone: nostra esperienza 142
STUDIO E COMPARAZIONE DELLE ALTERAZIONI DI FUNZIONALITA’ TIROIDEA INDOTTE DA INTERFERONE NEI SOGGETTI CON EPATITE CRONICA ATTIVA DA VIRUS C RISPETTO A SOGGETTI DI CONTROLLO 140
Clonal analysis of intrahepatic T lymphocytes in chronic active hepatitis. Isolation of a T-cell line specific for hepatitis B core antigen from a patient with serological evidence of exposure to HBV 140
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 139
Course of Graves' disease in interferon-treated patients with chronic hepatitis C virus infection and in uninfected patients 139
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 135
COMPOSTO FARMACEUTICO PER L’USO IN UN TRATTAMENTO TERAPEUTICO DELL’INFEZIONE CRONICA DA HBV E METODO PER L’IDENTIFICAZIONE DI LINFOCITI ESAURITI 134
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer 131
What to start with in first line treatment of chronic hepatitis B patients: an Italian multicentre observational cohort, HBV-RER study group 131
RNA Interference Therapy with ARC-520 Results in Prolonged HBsAg Response in Patients with Chronic Hepatitis B Infection 131
[Non-A, non-B hepatitis. Seroimmunological, epidemiological and clinical findings] 129
T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection 128
Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. 127
[The cell-mediated antiviral immune response. The possible therapeutic implications for chronic hepatitis B viral infection] 127
[Infectious agents in the G.I. tract diseases (author's transl)] 126
Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection 125
Clinical spectrum of cryoglobulinaemic neuropathy 124
A global scientific strategy to cure hepatitis B 123
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma. 123
Neoplastic macrovascular invasion represents an independent risk factor for dismal survival in sorafenib treatment for hepatocellular carcinoma 122
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B 121
Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells 120
Association of solid-phase assays to the indirect immunofluorescence in primary biliary cholangitis diagnosis: Results of an Italian multicenter study 120
Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens 119
Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming 118
A reduced grade of liver fibro-steatosis after raltegravir, maraviroc and fosamprenavir in an HIV/HCV co-infected patient with chronic hepatitis, cardiomyopathy, intolerance to nelfinavir and a marked increase of serum creatine phosphokinase levels probably related to integrase inhibitor use 118
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses 117
New perspectives for T-cell-based HCV vaccines 116
Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans 116
Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B 116
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection 116
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma 115
Clinical features of hepatitis delta virus infection in a northern Italian area 114
Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen 114
TRANSCRIPTOME ANALYSIS OF EXHAUSTED VIRUS-SPECIFIC CD8 T CELLS IN CHRONIC HBV INFECTION IDENTIFIES PROFOUND METABOLIC AND FUNCTIONAL CELL DEFECTS 114
A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection 114
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 113
[The immunopathogenesis of hepatitis B] 112
Fine specificity of the human T cell response to hepatitis B virus core antigen 112
Graves Disease In Interferon - Treated and Untreated Patients with Chronic Hepatitis C Virus Infection 111
Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines 111
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 109
Is steroid therapy needed in the treatment of destructive thyrotoxicosis induced by alpha-interferon in chronic hepatitis C? 108
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 108
Immune pathogenesis of hepatitis B 107
Comparative pathogenesis of HBV and HCV 107
[Hepatitis B virus infection in a hospital population in Parma: implementation of a vaccination program] 107
Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope 107
Oral lichen planus infiltrating T-cells:a Pathogenetic role for HCV-specific T cell responses? 106
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection 106
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C 106
Reorganization of a large academic hospital to face COVID-19 outbreak: The model of Parma, Emilia-Romagna region, Italy 105
Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen. 105
Comment on ‘End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB’ 105
T and B Cells in Hepatitis C Virus Control: What They Do and When They Fail 104
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 104
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B 104
Assessment of neutrophil gelatinase-associated lipocalin and lactate dehydrogenase in peritoneal fluids for the screening of bacterial peritonitis 104
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 103
Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study 102
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection 101
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV 101
Totale 14.098
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.191
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 0 35
2021/2022816 23 17 7 48 74 58 47 88 48 26 30 350
2022/20233.180 406 247 168 205 222 361 43 188 1.126 16 142 56
2023/20241.476 82 144 61 76 121 350 92 120 59 89 91 191
2024/20254.869 104 271 290 244 543 595 235 225 660 422 389 891
2025/202610.433 859 1.072 1.102 765 1.303 504 1.067 327 1.386 760 769 519
Totale 24.272